Literature DB >> 22593562

Gastric ulceration following oesophageal stent migration complicating surgical management of oesophageal cancer.

Sheraz R Markar1, Andrew Ross, Donald E Low.   

Abstract

Oesophageal, fully covered self-expanding metal stents (SEMS) allow palliation of dysphagia so as to support nutrition during neoadjuvant therapy. We present a 68-year old man with an oesophageal adenocarcinoma (T3N1M0) who had a fully covered oesophageal SEMS placed prior to neoadjuvant chemoradiotherapy. Repeat endoscopy 8 weeks later (for stent removal) showed that the stent had migrated and impacted upon the greater curvature of the stomach with a resultant ulcer. Surgery was delayed and, 10 weeks following the cessation of neoadjuvant chemoradiotherapy, this patient underwent a right thoracoabdominal oesophagogastrectomy. Operative findings included an erosion of the stent-induced gastric ulcer into the body of the pancreas and showed that the ulcerated tumour had become adherent to the thoracic aorta. This report demonstrates that the complications of stent migration can significantly impact upon surgical resection at multiple levels and provides a case for the routine removal of stents used in the neoadjuvant setting.

Entities:  

Mesh:

Year:  2012        PMID: 22593562      PMCID: PMC3397761          DOI: 10.1093/icvts/ivs211

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma.

Authors:  T Nozoe; Y Kimura; M Ishida; H Saeki; D Korenaga; K Sugimachi
Journal:  Eur J Surg Oncol       Date:  2002-06       Impact factor: 4.424

2.  Role of esophageal stents in benign and malignant diseases.

Authors:  Prateek Sharma; Richard Kozarek
Journal:  Am J Gastroenterol       Date:  2009-12-22       Impact factor: 10.864

3.  Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.

Authors:  M G C Pellen; S Sabri; A Razack; S Q Gilani; P K Jain
Journal:  Dis Esophagus       Date:  2011-05-19       Impact factor: 3.429

4.  Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.

Authors:  Matthew Bower; Whitney Jones; Ben Vessels; Charles Scoggins; Robert Martin
Journal:  Ann Surg Oncol       Date:  2009-07-28       Impact factor: 5.344

  4 in total
  2 in total

1.  eComment. Re: Gastric ulceration following oesophageal stent migration.

Authors:  Ewen A Griffiths; Susan L Powell
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08

2.  Diagnosis and surgical treatment of esophageal carcinoma with coexistent intrathoracic vascular malformations.

Authors:  Zhong-Xi Niu; Qiang Gao; Jun Peng; Hui Shi; Long-Qi Chen
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.